Haemonetics (HAE) Financials

$103.16

$0.32 (0.31%)

As on 09-Sep-2026 16:00EDT

Market cap

$4,679 Mln

Revenue (TTM)

$1,352 Mln

P/E Ratio

49.7

P/B Ratio

5.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Operating Revenue	1,352.01	1,334.03	1,360.82	1,309.06	1,168.66	993.20
Cost of Revenue	576.17	590.44	582.28	597.14	545.79	462.43
Gross Profit	775.84	743.59	778.55	711.92	622.87	530.77
Operating Expenses	530.10	502.19	556.73	547.03	466.84	450.02
Operating Profit (EBIT)	245.74	241.40	221.82	164.88	156.03	80.75
Other Income	--	--	--	--	-14.63	-17.12
Profit before Tax	130.44	128.03	212.07	151.87	141.40	63.63
Provision for Tax	34.15	30.72	44.39	34.31	26.00	20.25
Profit after Tax (Net Income)	96.29	97.31	167.68	117.56	115.40	43.38
Minority Interest	--	--	--	--	--	--
Consolidated Profit	83.42	--	167.68	117.56	115.40	43.38

Liabilities ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Shareholder's Funds	837.10	796.32	820.84	959.96	818.00	749.42
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1,265.06	1,317.01	1,052.00	935.25	865.01	668.04
Current Liabilities	263.24	282.60	578.11	300.38	251.82	442.27
Total Liabilities	2,628.64	2,395.93	2,450.95	2,195.59	1,934.83	1,859.73

Assets ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Non-Current Assets	1,554.57	1,561.05	1,515.97	1,426.69	1,165.10	1,103.70
Current Assets	810.83	834.88	934.98	768.90	769.72	756.03
Total Assets	2,628.64	2,395.93	2,450.95	2,195.59	1,934.83	1,859.73
Total Debt*	1,174.16	1,224.58	1,224.79	807.79	765.89	780.79
Net Current Assets	547.60	552.28	356.86	468.52	517.91	313.77

Cashflow ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Cash From Operating Activities	--	293.22	181.73	181.75	273.06	172.26
Cash Flow from Investing Activities	--	-179.55	-161.90	-322.39	-143.79	-86.35
Cash from Financing Activities	--	-178.46	108.82	38.16	-100.36	-15.75
Net Cash Inflow / Outflow	--	--	--	--	28.91	70.17

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Adjusted EPS ($)	2.05	2.11	3.39	2.29	2.25	0.84
Cash EPS ($)	--	4.52	5.73	4.18	4.07	2.75
Adjusted Book Value ($)	--	17.23	16.59	18.67	15.97	14.59
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	6.34	3.67	3.54	5.33	3.35
Free Cash Flow per Share ($)	--	5.63	2.88	2.79	3.18	1.48

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
ROCE (%)	--	4.79	8.79	7.01	7.41	2.85
ROE (%)	11.01	12.03	18.83	13.22	14.72	5.86
ROA (%)	3.43	4.02	7.22	5.69	6.08	2.36
EBIT Margin (%)	11.18	11.75	18.16	15.80	14.31	10.59
Net Margin (%)	7.12	7.29	12.32	8.98	10.00	4.44
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Revenue Growth (%)	0.44	-0.02	0.04	0.12	0.18	0.14
EBIT Growth (%)	-42.21	-36.57	19.47	23.71	58.98	5.07
Net Profit Growth (%)	-41.05	-41.97	42.64	1.87	166.05	-45.42
EPS Growth (%)	-37.43	-0.38	0.48	0.01	1.67	-0.46
Book Value Growth (%)	0.38	--	--	--	--	--

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Price / Earnings	49.69	26.77	18.75	37.32	36.73	74.85
Price / Book Value	5.54	3.27	3.83	4.57	5.18	4.33
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	20.67	11.47	11.41	16.97	18.73	19.65
Close Price ($)	75.00	56.36	63.55	85.35	82.75	63.22
High Price ($)	87.32	87.32	97.97	95.26	91.39	119.88
Low Price ($)	47.32	47.32	58.80	70.74	48.67	43.50
Market Cap ($ Cr)	4,679.37	--	--	--	--	--

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debt to Equity	1.40	1.54	1.49	0.84	0.94	1.04
Short term debt to equity ratio	0.01	0.01	0.37	0.01	0.01	0.30
Current Ratio	3.08	2.95	1.62	2.56	3.06	1.71
Quick Ratio	1.91	1.87	0.99	1.50	2.03	1.05
Interest Coverage	5.26	5.46	25.35	15.89	11.43	6.14

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debtors to sales (%)	15.98	16.26	14.89	15.78	15.33	16.05
Asset Turnover	0.48	0.55	0.59	0.63	0.62	0.54
Receivable days	--	57.43	54.92	53.81	52.90	52.76
Inventory Days	--	207.70	214.01	176.34	184.84	243.13
Payable days	--	36.51	44.02	41.99	40.92	42.91
Cash Conversion Cycle	--	228.62	224.91	188.16	196.82	252.98

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.